NR4A1 and breast carcinoma: The FFAR4 ligands with unabated quantities and elevated proportions remained the same regardless of hormone receptor status (Additional file 2: Tables S1 and S2), indicating that the FFAR4 ligands in situ are not likely regulated by hormone receptors in breast cancer tissues.